Over the last five years, the nanotechnology-based medical devices market witnessed tremendous growth primarily due to growth in the aging population, and increasing government support with increased nanotechnology R&D expenditure and increased international research collaborations.

In this report, the global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is segmented into therapeutics applications, diagnostics applications, and research applications.

The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent.

Active implantable devices accounted for a major share of the nanotechnology-based medical devices the market. The nanotechnology-based medical devices market for active implantable devices is primarily driven by the growing incidence of age-related disorders such as hearing and cardiovascular disorders. In addition, the growing awareness about these diseases and increased acceptance of the hearing aid devices are further driving the market for active implantable devices.

In 2013, North America accounted for the largest share to the global nanotechnology-based medical devices market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, rising adoption of advanced nanotechnology-based medical devices, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global nanotechnology-based medical devices market is dominated by six players that accounted for around 65-70% of the global market in 2014. The major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.).

Reasons To Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nanotechnology-based medical devices market. The report analyzes the nanotechnology-based medical devices market by products and applications across all regions

Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the nanotechnology-based medical devices market

Purchase this report

License Information

1-User PDF

This license allows for use of a report by one person. This person may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Unless a 5-User License, a Site License or an Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the report within the same enterprise. Customers who infringe these license terms are liable for an Enterprise license fee.

License Information

5-User PDF

This license allows for use of a report by five people within the same enterprise location. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Customers who infringe these license terms are liable for an Enterprise license fee.

License Information

Site PDF

This license allows for use of a report by an unlimited number of people within the same enterprise location (site). Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any person or persons outside of the enterprise location. Customers who infringe these license terms are liable for an Enterprise license fee.

License Information

Enterprise PDF

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons outside of the enterprise.